New Insights into Impairment of Mucosal Defense in Portal Hypertensive Gastric Mucosa

Journal of Gastrointestinal Surgery

Volumn 4, Issue 5, 2000, Pages 458-463

  Tomikawa, Morimasa ^a,b,e   Akiba, Yasunori ^c,d   Kaunitz, Jonathan D ^c,d   Kawanaka, Hirofumi ^a,b,e   Sugimachi, Keizo ^e   Sarfeb, I James ^a,b   Tarnawski, Andrzej S ^a,b  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e KYUSHU UNIVERSITY   (Japan)

Author keywords

Gastric mucosa; Mucosal defense; Mucosal oxygenation; Portal hypertension; Surface epithelial cell intracellular pH

Indexed keywords

ANIMAL; ARTICLE; BLOOD FLOW; EPITHELIUM; PATHOLOGY; PH; PORTAL HYPERTENSION; RAT; SPRAGUE DAWLEY RAT; STOMACH MUCOSA; VASCULARIZATION;

ANIMALS; EPITHELIUM; GASTRIC MUCOSA; HYDROGEN-ION CONCENTRATION; HYPERTENSION, PORTAL; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW;

EID: 0034268972     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(00)80086-4     Document Type: Article

References (38)

1. McCormack TT, Sims J, Eyre-Brook I. Gastric lesions in portal hypertension: Inflammatory or congestive? Gut 1985;26: 1226-1232.
2. Sarfeh IJ, Juler GL, Stemmer EA, Mason GR. Results of surgical management of hemorrhagic gastritis in patients with gastroesophageal varices. Surg Gynecol Obstet 1982;155:167-170.
3. Ohta M, Hashizume M, Higashi H, Ueno K, Tomikawa M, Kishihara F, Kawanaka H, Tanoue K, Sugimachi K. Portal and gastric mucosal hemodynamics in cirrhotic patients with portal-hypertensive gastropathy. Hepatology 1994;20:1432-1436.
4. Sarfeh IJ, Tarnawski M, Malki A, Mason GR, Mach T, Ivey KJ. Portal hypertension and gastric mucosal injury in rats. Effects of alcohol. Gastroenterology 1983;84:987-993.
5. Sarfeh IJ, Tarnawski A, Hajduczek A, Stachura J, Bui HX, Krause WJ. The portal hypertensive gastric mucosa: Histologic, ultrastructural, and functional analysis after aspirin induced damage. Surgery 1988;104:79-85.
6. Ishikawa T, Sarfeh IJ, Tarnawski A, Golshan R, Douglas T, Sugiyama M. Epidermal growth factor protects portal hypertensive gastric mucosa in ischemia/reperfusion: The role of capillary endothelia and prostaglandins. Surgery 1992;112: 341-346.
7. Hills BA, Butler BD, Lichtenberger LM. Gastric mucosal barrier, Hydrophobic lining to the lumen of the stomach. Am J Physiol 1983;244:G561-G568.
8. Arakawa T, Tarnawski A, Mach T, Kobayashi K, Sarfeh IJ. Impaired generation of prostaglandins from isolated gastric surface epithelial cells in portal hypertensive rats. Prostaglandins 1990;40:373-382.
9. Guth PH, Leung FW. Physiology of gastric circulation. In Johnson LR, ed. Physiology of the Gastrointestinal Tract, vol. 7. New York: Raven Press, 1987, pp 1031-1054.
10. Crissinger KD, Granger N. Gastrointestinal blood flow. In Yamada T, ed. Textbook of Gastroenterology, 2nd ed. Philadelphia: JB Lippincott, 1995, pp 518-545.
11. Kaneko K, Guth PH, Kaunitz JD. In vivo measurement of rat gastric surface cell intracellular pH. Am J Physiol 1991;261: G548-G552.
12. Nishizaki Y, Guth PH, Kaunitz JD. Isoproterenol enhances rat gastric mucosal barrier function in vivo. Gastroenterology 1993;105:340-346.
13. Kaunitz JD, Nishizaki Y, Kaneko K, Guth PH. Effect of orogastric nicotine on rat gastric mucosal gel thickness, surface cell viability and intracellular pH. J Pharmacol Exp Ther 1993;265:948-954.
14. Bonner RF, Clem TR, Bowen PD, Bowman RL. Laser-Doppler continuous real-time monitoring of pulsatile and mean blood flow in tissue microcirculation. In Chen SH, Chu B, Nossal R, eds. Scattering Techniques, Applied to Supra-Molecular and Nonequilibrium Systems. New York: Plenum, 1981, pp 685-702.
15. Sarfeh IJ, Soliman H, Waxman K, Coccia M, Rypins EB, Bui HX, Tarnawski A. Impaired oxygenation of gastric mucosa in portal hypertension: The basis for increased susceptibility to injury. Dig Dis Sci 1989;34:225-228.
16. Campbell MJ, Machin D. Correlation coefficient. In Campbell MJ, Machin D, eds. Medical Statistics, 2nd ed. Chichester: John Wiley & Sons, 1993, pp 152-153.
17. Allen A, Flemstrom G, Garner A, Kivilaakso E. Gastroduodenal mucosal protection. Physiol Rev 1993;73:823-857.
18. Wallace JL, Granger DN. The cellular and molecular basis of gastric mucosal defense. FASEB J 1996;10:731-740.
19. Nishizaki Y, Kaunitz JD, Oda M, Guth PH. Impairment of gastric mucosal defense measured in vivo in cirrhotic rats. Hepatology 1994;20:445-452.
20. 2 immunoactivity of gastric mucosa in portal hypertension. Neth J Med 1991;38:4-12.
21. Nishizaki Y, Guth PH, Kim G, Wayland H, Kaunitz JD. Pentagastrin enhances gastric mucosal defense in vivo: Luminal acid-dependent and independent effects. Am J Physiol 1994; 267:G94-G104.
22. Kitano S, Koyanagi N, Sugimachi K, Kobayashi M, Inokuchi K. Mucosal blood flow and modified vascular responses to norepinephrine in the stomach of rats with liver cirrhosis. Eur Surg Res 1982;14:221-230.
23. Vorobioff J, Bredfeldt JE, Groszmann RJ. Hyperdynamic circulation in portal hypertensive rat model: A primary factor for maintenance of chronic portal hypertension. Am J Physiol 1983;244:G52-G56.
24. Piqué JM, Leung FW, Kitahora T, Sarfeh TJ, Tarnawski A, Guth PH. Gastric mucosal blood flow and acid secretion in portal hypertensive rats. Gastroenterology 1988; 95:727-733.
25. Piqué JM, Pizcueta MP, Pérez RM, Bosch J. Effects of propranolol on gastric mucosal blood flow and acid secretion in portal hypertensive rats. Hepatology 1990;12:476-480.
26. Ichikawa Y, Tarnawski A, Sarfeh IJ, Ishikawa T, Shimada H. Distorted microangioarchitecture and impaired angiogenesis in gastric mucosa of portal hypertensive rats. Gastroenterology 1994;106:702-708.
27. Manabe T, Suzuki T, Honjo I. Changes of gastric blood flow in experimentally induced cirrhosis of the liver. Surg Gynecol Obstet 1978;147:753-757.
28. Hashizume M, Tanaka K, Inokuchi K. Morphology of gastric microcirculation in cirrhosis. Hepatology 1983;3:1008-1012.
29. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1998;333: 664-666.
30. Whittle BJR. Neuronal and endothelium-derived mediators in the modulation of the gastric microcirculation: Integrity in the balance. Br J Pharmacol 1993;110:3-17.
31. Lopez-Belmonte J, Whittle BJR, Moncada S. The actions of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa. Br J Pharmacol 1993;108:73-78.
32. Ferras JGP, Tigler A, Wallace JL. Paradoxical effects of L-arginine on gastric mucosal integrity. Eur J Pharmacol 1994;260:107-111.
33. Pizcueta MP, Pique JM, Bosch J, Whittle BJR, Moncada S. Effects of inhibiting nitric oxide biosynthesis on the systemic circulation of rats with portal hypertension. Br J Pharmacol 1992;105;184-L90.
34. Whittle BJR, Moncada S. Nitric oxide: The elusive mediator of the hyperdynamic circulation of cirrhosis? Hepatology 1992;16:1089-1092.
35. w-nitro-L-arginine ameliorates portal-systemic shunting in portal hypertensive rats. Gastroenterology 1993; 105:1464-1470.
36. Ohta M, Tanoue K, Tarnawski AS, Pai R, Itani RM, Sander FC, Sugimachi K, Sarfeh IJ. Overexpressed nitric oxide synthase in portal-hypertensive stomach of rat: A key to increased susceptibility to damage? Gastroenterology 1997;112:1920-1930.
37. Tarnawski A, Tomikawa M, Kawanaka H, Sugimachi K, Sarfeh IJ. Increased oxygen free radicals, nitrotyrosine and enhanced lipid peroxidation in portal hypertensive gastric mucosa: A key to increased susceptibility to injury. Gastroenterology 1999;116:A1282.
38. Kim H, Kim KH. Effect of nitric oxide on hydrogen peroxide-induced damage in isolated rabbit gastric glands. Pharmacology 1998;57:323-330.